Politics by David Aidone, staff writers 11th May 2021 12:00 AM
Premium Content
Subscriber only Treasurer Josh Frydenberg is set to hand down this year s budget from 7.30pm AEST, with billions of dollars expected to be spent on getting people back to work more than a year into the global pandemic. Those in aged care and working parents are tipped to be the big winners. From childcare subsidies to an infrastructure cash splash, here s what we already know is in it:
ECONOMY A post-COVID jobs boom is set to slash the forecast budget deficit by $53b this year. According to The Australian, the budget deficit for 2020-21 will be $161bn compared with the $213.7bn forecast in the October 6 budget.
INVO Bioscience to Report First Quarter 2021 Financial Results on Monday, May 17, 2021
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET
News provided by
Share this article
SARASOTA, Fla., May 11, 2021 /PRNewswire/
INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world s only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with infertility, will report financial results for its first quarter 2021, ended March 31, 2021, after the market close on Monday, May 17, 2021. The Company has scheduled a conference call that same day, Monday, May 17, 2021, at 4:30 pm ET, to review the results.
Federal Budget 2021: What we know qt.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from qt.com.au Daily Mail and Mail on Sunday newspapers.
INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global Brand Expansion
Aggressive go-to-market sales, partnerships, and marketing strategy to bring INVOcell, fertility care that is accessible, inclusive, and affordable to the more than 90% of couples in need of fertility treatment that currently go without care.
News provided by
Share this article
SARASOTA, Fla., May 10, 2021 /PRNewswire/
INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world s only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with infertility, is pleased to announce the appointment of tenured women s health & fertility solution marketing professional, Meryle Lynn Chamberlain, as Director of Marketing, a newly created position within the company.
Women s services are tipped to be a winner in the federal budget with $354 million packages being spread across the issues of cervical and breast cancer, endometriosis and reproductive health. Among the funding announced by federal health minister Greg Hunt and MP Dr Katie Allen on Sunday was a $100 million investment in improving cervical and breast cancer screening programs. Shadow Minister for Education and Shadow Minister for Women, Tanya Plibersek. Picture: NCA NewsWire / James Gourley There will also be a $96 million injection for new tests under the Medicare Benefits Scheme (MBS) for pre-implantation genetic testing of embryos for specific genetic or chromosomal abnormalities prior to pregnancy.